Skip to main content
Log in

Evaluation of potential therapies for COVID-19 global pandemic

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. including any used to specifically treat COVID-19 (including any medicines used off-label), and any medicines taken for the long-term management of pre-existing conditions.

  2. including patient information (including age and gender); whether COVID-19 infection was confirmed through testing, or was based on clinical symptoms; a description of the adverse reactions; the name of medicine (i.e. active ingredient + brand name) suspected to have caused the adverse reactions; the dose and duration of treatment with the medicine; and the batch number of the medicine.

References

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Evaluation of potential therapies for COVID-19 global pandemic. Reactions Weekly 1803, 2 (2020). https://doi.org/10.1007/s40278-020-78196-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-78196-3

Navigation